Provided by Tiger Trade Technology Pte. Ltd.

Lipocine

2.20
+0.04001.85%
Volume:31.37K
Turnover:69.21K
Market Cap:18.14M
PE:-1.21
High:2.25
Open:2.14
Low:2.08
Close:2.16
52wk High:12.37
52wk Low:1.81
Shares:8.24M
Float Shares:6.55M
Volume Ratio:0.73
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8181
EPS(LYR):-1.7669
ROE:-60.94%
ROA:-37.04%
PB:0.83
PE(LYR):-1.25

Loading ...

Lipocine Director John W. Higuchi Acquires 12,561 Common Shares Worth $27,131.76

Reuters
·
10 hours ago

Lipocine Price Target Announced at $4.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Lipocine (LPCN)

TIPRANKS
·
Sep 22

H.C. Wainwright sets $4 price target on Lipocine

TIPRANKS
·
Sep 22

Lipocine Highlights Strategy at Global Investor Conference

TIPRANKS
·
Sep 17

Lipocine initiates Phase 3 study of LPCN 1154 for postpartum depression

TIPRANKS
·
Sep 14

Lipocine - First Participant Dosing in Bloom Study Expected in Early Q4 2026

THOMSON REUTERS
·
Sep 14

Lipocine Announces Initiation of Bloom Phase 3 Study of Lpcn 1154 for Postpartum Depression

THOMSON REUTERS
·
Sep 14

Lipocine - Expects Average Cash Use of $1 Mln Per Month During Bloom Study Execution

THOMSON REUTERS
·
Sep 14

Lipocine Initiates BLOOM Phase 3 Trial of LPCN 1154 Oral Brexanolone for Postpartum Depression

Reuters
·
Sep 14

Lipocine Raises Sales Agent Fee to up to 3% Under Equity Distribution Agreement

Reuters
·
Sep 11

Lipocine to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 10

Lipocine 8-K/A Adds Michael Grissinger to Compensation Committee

Reuters
·
Aug 22

Lipocine Files Form 3 Initial Beneficial Ownership Statement for Director Michael Grissinger

Reuters
·
Aug 08

Vanda Pharmaceuticals Q2 Loss Widens on Lower Sales, Higher Costs

Reuters
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Lipocine (LPCN) and High Tide (HITI)

TIPRANKS
·
Aug 05

Lipocine Q2 2026 earnings: Missing license revenue drives top-line decline

TradingKey
·
Aug 05

Cumberland Pharmaceuticals Q2 Loss Widens After Apotex Transaction

Reuters
·
Aug 05

Niagen Bioscience Q2 Net Sales Fall, Missing Estimates

Reuters
·
Aug 05

Lipocine Q2 EPS USD -0.32

THOMSON REUTERS
·
Aug 04